NewAmsterdam Pharma Co NV (FRA:KH6) EV-to-Revenue : 97.31 (As of May. 15, 2024)

NewAmsterdam Pharma Co NV EV-to-Revenue Chart

Competitive Comparison of NewAmsterdam Pharma Co NV's EV-to-Revenue

For the Biotechnology subindustry, NewAmsterdam Pharma Co NV's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

NewAmsterdam Pharma Co NV's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, NewAmsterdam Pharma Co NV's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where NewAmsterdam Pharma Co NV's EV-to-Revenue falls into.

NewAmsterdam Pharma Co NV EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

NewAmsterdam Pharma Co NV's EV-to-Revenue for today is calculated as:

NewAmsterdam Pharma Co NV's current Enterprise Value is €1,263.42 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. NewAmsterdam Pharma Co NV's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was €12.98 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

NewAmsterdam Pharma Co NV  (FRA:KH6) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

NewAmsterdam Pharma Co NV's PS Ratiofor today is calculated as:

NewAmsterdam Pharma Co NV's share price for today is €17.80.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Dec. 2023 was €0.16.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

NewAmsterdam Pharma Co NV EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of NewAmsterdam Pharma Co NV's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

NewAmsterdam Pharma Co NV (FRA:KH6) Business Description